It is noteworthy, given the links between RalA and cancer, that the TD-60/RCC2 gene shows reduced copy number in >33% of breast, colon, lung and ovarian cancers catalogued in the COSMIC database47. This evidence concerns the gene RCC2 and ovarian carcinoma.